events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
Search
Login
events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
Login
News and Community
Blood Cancer Treatment
,
Fda Approval
,
Healthcare Technology
,
Mimrylo
,
Polycythemia Vera
,
Pv Treatment
,
Rusfertide
,
Takeda
September 1, 2026
Takeda Receives U.S. FDA Approval for MIMRYLO™, Potentially Shifting Polycythemia Vera Treatment
Clinical Tria
,
Eha2026
,
Essential Thrombocythemia
,
Pharmaessentia
,
Polycythemia Vera
,
Ropeginterferon Alfa-2b
May 25, 2026
PharmaEssentia Announces New Clinical Data for Ropeginterferon Alfa-2b in Essential Thrombocythemia at ASCO and EHA 2026
Load More